Skip to content

Chimeric Antigen Receptor

DRUG2 trials

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Ruijin Hospital

Conditions

LymphomaLymphoma, Non-Hodgkin